ECL ECOLAB INC.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 31462 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.3%
TTM net income YoY4.9%
TTM EPS YoY5.6%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR19.1%
Margins
Gross margin43.9%
Operating margin16.7%
Net margin12.0%
FCF margin10.3%
EBITDA margin20.9%
Returns
ROE20.7%
ROA7.6%
ROIC (approx.)12.1%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets66.4%
Debt / equity1.27x
Current ratio1.11x
Interest coverage7.42x
Cash quality & payout
Operating cash flow / net income1.45x
Accruals ratio-3.4%
Payout ratio39.3%
Capex / revenue7.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.69B | $4.42B | $4.07B | $4.20B | $4.17B | $4.03B | $3.69B | $4.01B |
| Cost of revenue | $2.63B | $2.47B | $2.30B | $2.35B | $2.30B | $2.22B | $2.06B | $2.27B |
| Gross profit | $2.07B | $1.95B | $1.77B | $1.85B | $1.87B | $1.80B | $1.63B | $1.74B |
| SG&A expense | $1.18B | $1.14B | $1.10B | $1.06B | $1.08B | $1.07B | $1.05B | $1.05B |
| Operating income | $810.50M | $757.90M | $622.00M | $712.00M | $760.20M | $710.10M | $555.30M | $582.80M |
| Interest expense | $135.80M | $95.00M | $77.30M | $82.90M | $74.60M | $76.20M | $72.60M | $79.20M |
| Pretax income | $694.50M | $693.60M | $558.10M | $660.30M | $717.70M | $659.90M | $510.00M | $534.30M |
| Income tax | $140.10M | $154.90M | $121.50M | $91.70M | $128.00M | $131.40M | $103.50M | $54.80M |
| Net income | $551.30M | $534.90M | $432.60M | $563.90M | $585.00M | $524.20M | $402.50M | $472.90M |
| EBITDA | $991.60M | $941.70M | $802.50M | $890.80M | $926.10M | $876.80M | $716.50M | $744.00M |
| EPS (basic) | 1.97 | 1.91 | 1.53 | — | 2.06 | 1.85 | 1.42 | 1.67 |
| EPS (diluted) | 1.95 | 1.90 | 1.52 | — | 2.05 | 1.84 | 1.41 | 1.66 |
| Dividends declared per share | 0.73 | 0.73 | 0.73 | 0.73 | 0.65 | 0.65 | 0.65 | 0.65 |
| Weighted avg. shares (diluted) | 282.10M | 282.20M | 283.70M | — | 285.40M | 285.40M | 285.30M | 285.70M |
| Balance sheet | ||||||||
| Cash & equivalents | $722.30M | $5.14B | $519.80M | $646.20M | $1.96B | $1.92B | $1.16B | $1.26B |
| Receivables | $3.80B | $3.45B | $3.28B | $3.25B | $3.11B | $3.06B | $2.86B | $2.87B |
| Inventory | $1.76B | $1.64B | $1.57B | $1.49B | $1.53B | $1.57B | $1.55B | $1.46B |
| Current assets | $7.10B | $11.02B | $6.04B | $5.96B | $7.11B | $7.08B | $6.08B | $6.03B |
| PP&E, net | $4.60B | $4.45B | $4.40B | $4.28B | $4.06B | $3.94B | $3.78B | $3.75B |
| Goodwill | $12.69B | $9.42B | $9.44B | $9.23B | $8.11B | $8.05B | $7.86B | $7.91B |
| Intangibles | $5.10B | $3.45B | $3.52B | $3.69B | $3.14B | $3.20B | $3.23B | $3.31B |
| Total assets | $31.11B | $29.93B | $25.04B | $24.70B | $23.90B | $23.74B | $22.37B | $22.39B |
| Current liabilities | $6.38B | $5.99B | $6.10B | $5.53B | $4.19B | $4.91B | $4.61B | $4.79B |
| Short-term debt | $1.28B | $1.27B | $1.57B | $870.40M | $16.20M | $688.50M | $614.20M | $615.70M |
| Long-term debt | $11.92B | $11.91B | $6.92B | $7.37B | $8.05B | $7.52B | $7.00B | $6.95B |
| Total debt | $13.19B | $13.18B | $8.50B | $8.24B | $8.07B | $8.21B | $7.61B | $7.56B |
| Total liabilities | $20.65B | $19.84B | $15.01B | $14.89B | $14.14B | $14.39B | $13.46B | $13.60B |
| Shareholders' equity | $10.42B | $10.06B | $10.00B | $9.77B | $9.72B | $9.32B | $8.88B | $8.76B |
| Net debt | $12.47B | $8.04B | $7.98B | $7.59B | $6.11B | $6.29B | $6.45B | $6.31B |
| Shares outstanding | 280.50M | 280.30M | 281.40M | 282.00M | 283.20M | 283.60M | 283.50M | 283.40M |
| Cash flow statement | ||||||||
| Operating cash flow | $763.70M | $729.50M | $445.90M | $1.09B | $791.30M | $701.80M | $369.40M | $766.70M |
| Capital expenditure | $313.40M | $240.10M | $348.50M | $332.10M | $261.60M | $216.70M | $237.90M | $359.70M |
| Free cash flow | $450.30M | $489.40M | $97.40M | $758.00M | $529.70M | $485.10M | $131.50M | $407.00M |
| Investing cash flow | -$4.99B | -$274.00M | -$355.50M | -$1.98B | -$280.60M | -$224.40M | -$224.00M | -$627.50M |
| Financing cash flow | -$173.60M | $4.15B | -$225.80M | -$431.60M | -$477.40M | $297.30M | -$241.60M | -$140.10M |
| Depreciation & amortization | $181.10M | $183.80M | $180.50M | $178.80M | $165.90M | $166.70M | $161.20M | $161.20M |
| Stock-based compensation | $40.90M | $34.80M | $40.30M | $27.10M | $33.60M | $33.70M | $42.20M | $25.30M |
| Dividends paid | $204.60M | $208.20M | $215.90M | $189.20M | $184.40M | $188.00M | $192.00M | $161.40M |
| Share buybacks | $2.80M | $324.90M | $344.40M | $409.20M | $175.40M | $45.50M | $153.70M | $2.80M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.